A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 232 participants.
Also called NCT06649110
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 1/2
- Enrolled
- 232 participants
- Sponsor
- Registry
-
NCT06649110
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Argentina, Australia, Belgium, Brazil, Czechia, France, Germany, Greece, Italy, Latvia, Mexico, Poland, Portugal, Romania, Serbia, Spain, United Kingdom
- Registry status
- Recruiting
Technical summary
Registry record NCT06649110. Randomized; double masking; primary purpose treatment. Start 2024-10-24 (actual); primary completion 2028-11-29 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
- Condition
- Healthy Volunteers, Pulmonary Arterial Hypertension
- Intervention (Drug)
- LTP
- Intervention (Drug)
- Placebo
- Lead sponsor
- Novartis Pharmaceuticals
Record details
- Record id
cardio:ct-nct06649110- Content hash
3da417d8ea1af1dabde08b69c03f4cc952a8ee2c6c9d8129dc27ba0750126236